Skip to content
Combatting Superbugs and Emerging Viruses episode artwork

Jul 14, 2022 22 min

Combatting Superbugs and Emerging Viruses

from The Bio Report Hosted by Levine Media Group

The rise of antibiotic resistance and the threat of emerging viral pathogens have created global public health threats. Recce Pharmaceuticals is developing a new class of synthetic anti-infectives that it says can overcome the hyper-cellular mutation of bacteria and viruses. What’s more, the company says their potency doesn’t diminish even with repeated use. We spoke to James Graham, CEO of Recce, about its synthetic anti-infectives, how they work, and why they can be used repeatedly against a broad range of bacteria and viruses.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Combatting Superbugs and Emerging Viruses

0:00 22:04

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 22 minutes long.

When was this The Bio Report episode published?

This episode was published on July 14, 2022.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.